1,089 results on '"Postma, D. S."'
Search Results
402. The Many Faces of Airway Inflammation
403. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis
404. Characteristics of Airway Hyperresponsiveness in Asthma and Chronic Obstructive Pulmonary Disease
405. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough
406. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study
407. When can an exacerbation of COPD be treated at home?
408. The significance of airway responsiveness in the onset and evolution of chronic obstructive pulmonary disease
409. Decline of FEV1 by age and smoking status: facts, figures, and fallacies
410. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators
411. Adult patients may outgrow their asthma: a 25-year follow-up study.
412. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
413. Picumeterol: dissociation of improvement in lung function and reduction of airways hyperresponsiveness in asthmatics
414. Asthma: from childhood to adulthood
415. Seasonal variations in house dust mite influence the circadian peak expiratory flow amplitude.
416. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids
417. PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20-70 yr).
418. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
419. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids
420. Long-term effects of home rehabilitation on physical performance in chronic obstructive pulmonary disease.
421. Home assessment of peak inspiratory flow through the Turbohaler in asthmatic patients.
422. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms.
423. Ultrastructural immunogold localization of interleukin 5 to the crystalloid core compartment of eosinophil secondary granules in patients with atopic asthma.
424. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
425. Cell surface antigen expression by peripheral blood monocytes in allergic asthma: results of 2.5 years therapy with inhaled beclomethasone dipropionate
426. Exogenous stimuli and circadian peak expiratory flow variation in allergic asthmatic children.
427. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids.
428. Dutch approach to the study of the genetics of asthma
429. House dust mite exposure in asthmatic and healthy children: the difference is carpeting
430. The genetics of asthma and atopy
431. Comments on defining the asthma phenotype
432. Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: a major regulatory locus important in asthma
433. Two locus segregation and linkage analysis for total serum IgE levels
434. The role of airway inflammation in the pathophysiology of nocturnal asthma noeturnal asthma
435. Effects of propranolol inhalation on the diurnal increase in FEV1 and on propranolol airways responsiveness in atopic subjects with asthma.
436. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.
437. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults
438. Mite-specific IgE cannot be used as a surrogate for mite exposure
439. Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group.
440. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults.
441. Mouth pressures during pursed lip breathing
442. Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma.
443. AUTHORS' REPLY
444. Lower leukotriene C4 levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy
445. Abstracts of papers and posters
446. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.
447. Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary disease.
448. Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group.
449. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
450. Reliability and validity of the chronic respiratory questionnaire (CRQ).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.